NYSE:DNA - New York Stock Exchange, Inc. - US37611X2099 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 43% to DNA. The Buy consensus is the weighted average rating of the current analysts ratings.
Date | Firm | Action | Rating |
---|---|---|---|
2024-09-20 | TD Cowen | Maintains | Buy -> Buy |
2024-08-23 | BTIG | Maintains | Sell -> Sell |
2024-07-09 | Goldman Sachs | Maintains | Sell -> Sell |
2024-06-26 | BTIG | Maintains | Sell -> Sell |
2024-05-15 | BTIG | Downgrade | Neutral -> Sell |
2024-05-15 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
2024-05-10 | William Blair | Downgrade | Market Perform -> Underperform |
2024-03-01 | TD Cowen | Maintains | Outperform -> Outperform |
2024-01-23 | Goldman Sachs | Maintains | Sell -> Sell |
2024-01-22 | Goldman Sachs | Maintains | Sell -> Sell |
2023-11-15 | Raymond James | Downgrade | Outperform -> Market Perform |
2023-11-14 | Raymond James | Downgrade | Outperform -> Market Perform |
2023-11-09 | BTIG | Downgrade | Buy -> Neutral |
2023-06-05 | Goldman Sachs | Maintains | Sell -> Sell |
2023-06-02 | Goldman Sachs | Downgrade | Neutral -> Sell |
2023-05-11 | William Blair | Downgrade | Outperform -> Market Perform |
2022-11-29 | Berenberg | Initiate | Buy |
2022-10-04 | Morgan Stanley | Initiate | Equal-Weight |
2022-08-16 | BTIG | Maintains | Buy |
2022-08-16 | Raymond James | Maintains | Outperform |
2022-06-16 | Jefferies | Maintains | Buy |
2022-05-18 | B of A Securities | Downgrade | Neutral -> Underperform |
2022-03-02 | Cowen & Co. | Initiate | Outperform |
2022-02-23 | Goldman Sachs | Initiate | Neutral |
2022-02-01 | B of A Securities | Initiate | Neutral |
2022-01-28 | B of A Securities | Initiate | Buy |
2022-01-07 | BTIG | Initiate | Buy |
2021-10-13 | Raymond James | Initiate | Outperform |
2021-10-12 | William Blair | Initiate | Outperform |
2021-09-20 | HSBC | Initiate | Buy |